AI Article Synopsis

  • The study investigates a specific mechanism behind immune tolerance in bone marrow transplantation (BMT) using nonmyeloablative total lymphoid irradiation and rabbit anti-thymocyte serum (TLI/ATS) conditioning, highlighting the role of recipient immune cells in promoting donor regulatory T cell proliferation.
  • Following the transplantation of donor cells lacking STAT6 (a protein involved in immune response), it was revealed that recipient cells, not the donors, are responsible for facilitating the growth of donor regulatory T cells, particularly through specific CD11b(+) cell subsets.
  • The research indicates that these recipient-derived CD11b(+) cells, especially the Gr-1(low)CD11c(+) subset, are crucial for inducing the necessary immune

Article Abstract

We showed previously that nonmyeloablative total lymphoid irradiation/rabbit anti-thymocyte serum (TLI/ATS) conditioning facilitates potent donor-recipient immune tolerance following bone marrow transplantation (BMT) across MHC barriers via recipient invariant NKT (iNKT) cell-derived IL-4-dependent expansion of donor Foxp3(+) naturally occurring regulatory T cells (nTregs). In this study, we report a more specific mechanism. Wild-type (WT) BALB/c (H-2(d)) hosts were administered TLI/ATS and BMT from WT or STAT6(-/-) C57BL/6 (H-2(b)) donors. Following STAT6(-/-) BMT, donor nTregs demonstrated no loss of proliferation in vivo, indicating that an IL-4-responsive population in the recipient, rather than the donor, drives donor nTreg proliferation. In graft-versus-host disease (GVHD) target organs, three recipient CD11b(+) cell subsets (Gr-1(high)CD11c(-), Gr-1(int)CD11c(-), and Gr-1(low)CD11c(+)) were enriched early after TLI/ATS + BMT versus total body irradiation/ATS + BMT. Gr-1(low)CD11c(+) cells induced potent H-2K(b+)CD4(+)Foxp3(+) nTreg proliferation in vitro in 72-h MLRs. Gr-1(low)CD11c(+) cells were reduced significantly in STAT6(-/-) and iNKT cell-deficient Jα18(-/-) BALB/c recipients after TLI/ATS + BMT. Depletion of CD11b(+) cells resulted in severe acute GVHD, and adoptive transfer of WT Gr-1(low)CD11c(+) cells to Jα18(-/-) BALB/c recipients of TLI/ATS + BMT restored day-6 donor Foxp3(+) nTreg proliferation and protection from CD8 effector T cell-mediated GVHD. Blockade of programmed death ligand 1 and 2, but not CD40, TGF-β signaling, arginase 1, or iNOS, inhibited nTreg proliferation in cocultures of recipient-derived Gr-1(low)CD11c(+) cells with donor nTregs. Through iNKT-dependent Th2 polarization, myeloid-derived immunomodulatory dendritic cells are expanded after nonmyeloablative TLI/ATS conditioning and allogeneic BMT, induce PD-1 ligand-dependent donor nTreg proliferation, and maintain potent graft-versus-host immune tolerance.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863612PMC
http://dx.doi.org/10.4049/jimmunol.1302191DOI Listing

Publication Analysis

Top Keywords

ntreg proliferation
20
tli/ats bmt
16
gr-1lowcd11c+ cells
16
immune tolerance
12
myeloid-derived immunomodulatory
8
cells
8
induce pd-1
8
pd-1 ligand-dependent
8
donor
8
ligand-dependent donor
8

Similar Publications

IL-6 induces Treg dysfunction in desiccating stress-induced dry eye disease.

Exp Eye Res

September 2024

Laboratory of Ocular Immunology, Transplantation, and Regeneration, Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. Electronic address:

Article Synopsis
  • Regulatory T cells (Tregs) are essential for keeping the immune system balanced, and their malfunction is linked to autoimmune diseases like dry eye disease (DED).
  • In the study, Tregs from DED mice showed lower levels of key functional markers and higher expression of pro-inflammatory cytokine receptors, particularly IL-6, which negatively affected their ability to suppress inflammatory T-helper cells.
  • Blocking IL-6 in DED models improved Treg function and reduced disease severity, suggesting that targeting IL-6 could lead to new treatments for managing DED by restoring Treg activity.
View Article and Find Full Text PDF

Background: Both the crystalline and soluble forms of cholesterol increase macrophage secretion of interleukin 1β (IL-1β), aggravating the inflammatory response in atherosclerosis (AS). However, the link between cholesterol and regulatory T cells (Tregs) remains unclear. This study aimed to investigate the effect of cholesterol treatment on Tregs.

View Article and Find Full Text PDF

Natural killer (NK) cells play a crucial role in the anti-tumor transaction through cytolytic activity with the help of proportionate expression of their activating receptors (ARs) and inhibitory receptors (IRs). The proliferation, differentiation, and effector's functions of NK cells were affected and regulated by CD4CD25 regulatory T (Treg) cells through the NKG2D receptor expressed on NK cells. It has not yet been established whether Treg cells also affects the expression and functions of other receptors of NK cell.

View Article and Find Full Text PDF

Protocol for in vitro isolation, induction, expansion, and determination of human natural regulatory T cells and induced regulatory T cells.

STAR Protoc

December 2022

Hepatobiliary Center of the First Affiliated Hospital, Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, Jiangsu 210029, China. Electronic address:

Regulatory T cells (Tregs) can inhibit the occurrence of autoimmune diseases and increase the activation threshold of the immune response. Here, we present schemes for the isolation and culture of natural human regulatory T cells (nTregs) and in vitro-induced Tregs (iTregs). Appropriate concentrations of TGF-β, IL-2, retinoic acid (atRA), and rapamycin were used to promote proliferation to meet sample needs in basic research, especially in technologies such as sequencing.

View Article and Find Full Text PDF

Distepharinamide, a novel dimeric proaporphine alkaloid from Diploclisia glaucescens, inhibits the differentiation and proliferative expansion of CD4Foxp3 regulatory T cells.

Phytomedicine

December 2022

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Science, University of Macau, Macau 999078, China. Electronic address:

Background: CD4Foxp3 regulatory T cells (Tregs) represent the primary cellular mechanism of tumor immune evasion. Elimination of Treg activity by the pharmacological agent may enhance anti-tumor immune responses. However, Treg-eliminating agents, especially those with small molecules, are rarely reported.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!